Intchains Group (NASDAQ:ICG – Get Free Report) and Firefly Neuroscience (NASDAQ:AIFF – Get Free Report) are both small-cap business services companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, profitability, valuation, dividends and risk.
Profitability
This table compares Intchains Group and Firefly Neuroscience’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Intchains Group | 36.01% | 8.98% | 8.56% |
| Firefly Neuroscience | -2,705.88% | -319.00% | -191.27% |
Earnings and Valuation
This table compares Intchains Group and Firefly Neuroscience”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Intchains Group | $38.60 million | 2.83 | $7.05 million | $0.21 | 8.57 |
| Firefly Neuroscience | $110,000.00 | 134.90 | -$10.46 million | ($2.09) | -0.53 |
Intchains Group has higher revenue and earnings than Firefly Neuroscience. Firefly Neuroscience is trading at a lower price-to-earnings ratio than Intchains Group, indicating that it is currently the more affordable of the two stocks.
Insider and Institutional Ownership
5.0% of Firefly Neuroscience shares are held by institutional investors. 6.4% of Firefly Neuroscience shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Analyst Ratings
This is a breakdown of recent recommendations and price targets for Intchains Group and Firefly Neuroscience, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Intchains Group | 1 | 1 | 2 | 0 | 2.25 |
| Firefly Neuroscience | 1 | 0 | 0 | 0 | 1.00 |
Intchains Group currently has a consensus target price of $7.50, indicating a potential upside of 316.67%. Given Intchains Group’s stronger consensus rating and higher probable upside, equities research analysts plainly believe Intchains Group is more favorable than Firefly Neuroscience.
Volatility & Risk
Intchains Group has a beta of 1.39, suggesting that its share price is 39% more volatile than the S&P 500. Comparatively, Firefly Neuroscience has a beta of 1.85, suggesting that its share price is 85% more volatile than the S&P 500.
Summary
Intchains Group beats Firefly Neuroscience on 10 of the 14 factors compared between the two stocks.
About Intchains Group
Intchains Group Limited designs and sells application-specific integrated circuit chips for blockchain applications in the People's Republic of China. The company also offers ancillary software, hardware, and other products. It serves distributors. Intchains Group Limited was founded in 2017 and is based in Pudong, China.
About Firefly Neuroscience
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.
Receive News & Ratings for Intchains Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intchains Group and related companies with MarketBeat.com's FREE daily email newsletter.
